Fosamax and Malignant pleural effusion - a phase IV clinical study of FDA data

Summary:

Malignant pleural effusion is reported as a side effect among people who take Fosamax (alendronate sodium), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Zometa, and have Breast cancer.

The phase IV clinical study analyzes which people have Malignant pleural effusion when taking Fosamax. It is created by eHealthMe based on reports of 104,411 people who have side effects when taking Fosamax from the FDA, and is updated regularly.

What is Fosamax?

Fosamax has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 105,452 Fosamax users. Check the latest studies of Fosamax.

What is Malignant pleural effusion?

Malignant pleural effusion (a condition in which cancer causes an abnormal amount of fluid to collect between the thin layers of tissue lining of lung) is found to be associated with 356 drugs and 448 conditions by eHealthMe. Check the latest studies of Malignant pleural effusion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

104,411 people reported to have side effects when taking Fosamax.
Among them, 20 people (0.02%) have Malignant pleural effusion.

Could Fosamax cause Malignant pleural effusion?

Among these 20 people:

How long have people been on Fosamax when they have Malignant pleural effusion? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Malignant pleural effusion when taking Fosamax? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Malignant pleural effusion when taking Fosamax? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Fosamax? *

  1. Zometa: 12 people, 60.00%
  2. Neurontin: 9 people, 45.00%
  3. Ambien: 9 people, 45.00%
  4. Arimidex: 9 people, 45.00%
  5. Elavil: 7 people, 35.00%
  6. Naprosyn: 7 people, 35.00%
  7. Mobic: 7 people, 35.00%
  8. Metoclopramide: 7 people, 35.00%
  9. Medrol: 7 people, 35.00%
  10. Lorazepam: 7 people, 35.00%

What are other side effects people have besides Malignant pleural effusion? *

  1. Dental Caries: 12 people, 60.00%
  2. Osteonecrosis Of Jaw (death of bone of jaw): 12 people, 60.00%
  3. Tooth Abscess (pus formation in tooth): 12 people, 60.00%
  4. Weakness: 11 people, 55.00%
  5. Herpes Zoster: 9 people, 45.00%
  6. Tooth Disorder (tooth disease): 9 people, 45.00%
  7. Back Pain: 9 people, 45.00%
  8. Urinary Tract Infection: 9 people, 45.00%
  9. Dyspnea (difficult or laboured breathing): 9 people, 45.00%
  10. Atelectasis (partial or complete collapse of the lung): 8 people, 40.00%

What are the existing conditions these people have? *

  1. Breast Cancer: 12 people, 60.00%
  2. Stress And Anxiety: 7 people, 35.00%
  3. Metastases To Bone (cancer spreads to bone): 7 people, 35.00%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 35.00%
  5. Bone Pain: 7 people, 35.00%
  6. Breast Cancer Metastatic: 6 people, 30.00%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 20.00%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 10.00%
  9. Colon Cancer: 1 person, 5.00%
  10. Breast Cancer Recurrent: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fosamax and have Malignant pleural effusion?

- Check whether Malignant pleural effusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fosamax:

Malignant pleural effusion treatments and more:

How severe was Malignant pleural effusion and when was it recovered:

Expand to all the drugs that have ingredients of alendronate sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fosamax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Malignant pleural effusion:

Browse all the conditions that are associated with Malignant pleural effusion:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on alendronate sodium (the active ingredients of Fosamax) and Fosamax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: